IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Inotek Pharmaceuticals Corp

CUSIP: 45780V102 | 142 institutional holders

Quarters

Q3 2021Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2021

Ovata Capital Management Ltd7,500
0.0% of portfolio›$224
StyleTurnoverLocationFiled
Ovata Capital Management Ltd
7,500$2240.0%ValueVery HighHong Kong, South Korea2021-11-15